Keywords
How to Cite
Abstract
The Duchenne muscular dystrophy is a bound serious muscular illness to the X-linked chromosome that affects to the gene that codes the dystrophin, protein important for the maintenance of the muscle fiber. It is characterized by muscle weakness of beginning in the childhood that follows a progressive course. Without intervention some, the patients lose the march before the younger and the death happens in the second decade of life for breathing complications or heart problems. At the moment it doesn't exist healing treatment, but the therapy with corticosteroids and the handling several disciplines and orthopedic they modify the natural history of this muscle disorders. In this article, we present two clinical cases of children who had difficulty prefoming vigorous physical actives. Diagnosis of Duchenne muscular dystrophy confirmed by creatin phosphokinase and electromyography with improvement of the clinical picture thanks to the treatment provided
Camacho A. Distrofia muscular de Duchenne. An Pediatric Contin. 2014;12(2):47-54.
Online Mendelian Inheritance in Man (OMIM) [internet]. 2015 [citado 2015 mar]. Disponible en: http://www.ncbi.nlm.nih.gov/Omim/
Turnpenny P, Ellard S. Emery´s elements of medical genetics. 13a ed. Edimburgo: Elsevier Limited; 2007.
Biggar D. Duchenne muscular dystrophy. Peds in Review. 2015;27(3):83-8.
Lyons K. SMITH: patrones reconocibles de malformaciones humanas. 6a ed. Barcelona: Elsevier Saunders; 2008.
Mercier S, Toutain A, Toussaint A, Raynawd M, Barace C, Marcorelles P, et al. Genetic and clinical specifity of 26 symptomatic carriers for dystrophino pathies at pediatric age. Europ J H Gent. 2013;21(1):855-63.
Coral R, López L, Ruano L, Gómez B, Fernández F, Bahena E. Distrofias musculares en México: un enfoque clínico, bioquímico y molecular. Rev de Esp Med-Quirur (México). 2014;15(3):152-60.
Kleinsteuber K, Avaria M. Enfermedades neuromusculares en pediatría. Rev Ped Elec. 2013;2(1);52-61.
Cammarata F, Camacho N, Alvarado J, Lacruz M. Distrofia muscular de Duchenne: presentación clínica. Rev Chil Pediatric. 2013;79(5):495-501.
Chaustre D, Chona W. Distrofia muscular de Duchenne: perspectivas de Rehabilitación. Rev Med. 2011;19(1):44-55.
Dietz H, Feero W, Guttmacher A. New therapeutic approaches to Mendelian disorders. N Engl J Med. 2012;363(9):852-63.
Bushby K, Finkel R, Birnkrant D, Laura E, Clemens P, Cripe L, et al. Diagnóstico y tratamiento de la distrofia muscular de Duchenne. Lancet Neurol. 2014;9(1):77-93.
Lantigua A. Introducción a la genética médica. 2a ed. La Habana: Ciencias Médicas; 2011.
Fonseca D, Arbeláez H, Silva C. Pérdida de heterocigocidad e identificación de portadores de distrofia muscular de Duchenne: un caso familiar con evento de recombinación. Rev Cienc Salud. 2012;10(1):83-90.
Ministerio de Salud Pública de Ecuador. Manual de prevención de riesgos de discapacidad en perineonatología. Quito: MSP; 2014.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.